Preparation of capecitabine-poly(p-dioxanone) electrospraying nanoparticles and influence of particle size on their colorectal cancer inhibitive efficiency

Abstract

Colorectal cancer is the fourth leading cause of cancer-related deaths worldwide. Capecitabine is a chemotherapeutic agent commonly used for the treatment of colon cancer. To realize local sustained release, promote efficient local intracellular transport, and mitigate the systemic toxic effects of capecitabine, a capecitabine prodrug, capecitabine-poly (p-dioxanone) (Cap-PPDO), was successfully synthesized. Cap-PPDO was subsequently processed into nanoscale particles with various diameters using electrospraying to investigate the influence of nanoparticle (NP) size on the therapeutic efficiency of Cap-PPDO NPs. Design Expert Software was used to design an experimental scheme for evaluating the influence of electrospraying parameters on NP size and distribution. The in vitro capecitabine release rate of Cap-PPDO NPs was evaluated, and NPs with a size of approximately 300 nm demonstrated the fastest release rate. However, Cap-PPDO NPs with a size of approximately 300 nm exhibited lower proliferation inhibition against SW480 colorectal cancer compared to those with diameters of 200 and 400 nm. To further elucidate the influence of size, the endocytosis of SW480 cells with respect to these differently sized NPs was investigated using flow cytometry and transmission electron microscopy (TEM), given that endocytosis is an important pathway for the intracellular delivery of nanoparticles. The mechanism underlying the size-dependent therapeutic efficiency of Cap-PPDO NPs was ultimately attributed to the size of the mammalian lysosome. Finally, the therapeutic efficacy of Cap-PPDO NPs of various sizes was verified using a nude mouse model of SW480 cell-transplanted tumors.

Graphical Abstract

Keywords

Colorectal cancer capecitabine prodrug electrospraying nanoscale particles drug delivery system

Get full access to this article

View all access options for this article.

References

Dekker

Tanis

Vleugels

JLA

, et al. Colorectal cancer. Lance 2019; 394: 1467–1480.

André

Boni

Navarro

, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109–3116.

Zhong

Xiong

, et al. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduct Targeted Ther 2021; 6: 201.

Gao

Wang

Zhang

, et al. Multifunctional nanoparticle for cancer therapy. MedComm 2023; 4: e187.

Ryu

Park

Lee

, et al. Biodegradable nanoparticles-loaded PLGA microcapsule for the enhanced encapsulation efficiency and controlled release of hydrophilic drug. Int J Mol Sci 2021; 22: 2792.

Wang

Xiong

Zhu

, et al. A pH-responsive nanoplatform based on fluorescent conjugated polymer dots for imaging-guided multitherapeutics delivery and combination cancer therapy. ACS Biomater Sci Eng 2022; 8: 161–169.

Barua

Mitragotri

. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today 2014; 9: 223–243.

Bareford

Swaan

. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev 2007; 59: 748–758.

Wang

Jansen

Yang

. Electrospraying: possibilities and challenges of engineering carriers for biomedical applications-a mini review. Front Chem 2019; 7: 258.

10.

Niua

Shaoa

Luo

, et al. Recent advances of electrosprayed particles as encapsulation systems of bioactives for food application. Food Hydrocoll 2020; 99: 105376.

11.

Haller

Tabernero

Maroun

, et al. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol 2011; 29: 1465–1471.

12.

Ghaffarzadegan

Khoee

Rezazadeh

. Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release. DARU J Pharm Sci 2020; 28: 237–252.

13.

Zhou

Han

Aras

, et al. Recent advances in paclitaxel-based self-delivery nanomedicine for cancer therapy. Curr Med Chem 2021; 28: 6358–6374.

14.

Kim

Lee

, et al. Effect of shear viscosity on the preparation of sphere-like silk fibroin microparticles by electrospraying. Int J Biol Macromol 2015; 79: 988–995.

15.

Knockaert

Pulissery

Lemmens

, et al. Carrot β-carotene degradation and isomerization kinetics during thermal processing in the presence of oil. J Agric Food Chem 2012; 60: 10312–10319.

16.

Raghavan

Emekalam

. Combination of atomic force microscopy and chemical hydrolysis to characterize degradable regions in polymer blends. J Appl Polym Sci 2006; 100: 726–733.

17.

Muthuraj

Misra

Mohanty

. Hydrolytic degradation of biodegradable polyesters under simulated environmental conditions. J Appl Polym Sci 2015; 132: 42189.

18.

Foged

Brodin

Frokjaer

, et al. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm (Amst) 2005; 298: 315–322.

19.

Islam

Barua

. A multiscale modeling study of particle size effects on the tissue penetration efficacy of drug-delivery nanoparticles. BMC Syst Biol 2017; 11: 113.

20.

Foroozandeh

Aziz

. Insight into cellular uptake and intracellular trafficking of nanoparticles. Nanoscale Res Lett 2018; 13: 339.

21.

Manzanares

Ceña

. Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell. Pharmaceutics 2020; 12: 371.

22.

Ren

. Lysosomal physiology. Annu Rev Physiol 2015; 77: 57–80.

23.

Klionsky

Eskelinen

. The vacuole vs. the lysosome. Autophagy 2014; 10: 185–187.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.18 MB